EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence and factors associated with liver fibrosis among adults with chronic hepatitis B infection at the Mbarara Regional Referral Hospital

P. Ucama

Journal of Kenya Assocation of Physicians · 2024

DOI: 10.4314/jkap.v6i2.16a ↗
AbstractBibliografische Angaben

Abstract

Background: The prevalence of chronic hepatitis B is high in low- and middle-income countries, with rates exceeding 8% in sub- Saharan Africa. Liver fibrosis is a crucial stage in the progression of hepatitis B-related liver disease, leading to severe complications like cirrhosis and hepatocellular carcinoma. Transient elastography, a non-invasive test for detecting liver scarring, has improved liver fibrosis assessment, providing a practical alternative to liver biopsy. However, there is limited local data on the prevalence and determinants of liver fibrosis among adults with chronic hepatitis B infection using transient elastography.Objectives: The aim of this study was to determine the prevalence and factors associated with liver fibrosis among patients with chronic hepatitis B infection at Mbarara Regional Referral Hospital (MRRH).Methods: We conducted a cross-sectional study from November 2023 to March 2024 at the MRRH hepatitis clinic. We consecutively consented and enrolled patients aged ≥18 years who had persistent positive HepBsAg test for more than 6 months. Data on socio-demographic, comorbidities, laboratory parameters were collected and transient elastography was performed. Liver fibrosis was considered in patients who had liver stiffness measurement above 7 kPa. The prevalence of liver fibrosis was expressed as a percentage. We used logistic regression analysis to determine the factors associated with liver fibrosis.Results: A total of 96 participants were consecutively enrolled. The median age was 33.5 (IQR 26-42.5) years, and 58 (69.4%) were males. The median liver stiffness measurement was 6 (IQR 4.8-8.0) kPa. The prevalence of liver fibrosis was 35.5% (95% C.I, 26.4-45.5). Having hepatitis B viral load ≥ 20,000 IU/ml (aOR, 10.9; 95% C.I, 3.2 - 37.2; p < 0.001), elevated ALT ≥ 42 IU (aOR, 9.5; 95% C.I, 2.2 – 39.4; p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →